Anupam Rasayan India Limited, through its wholly owned subsidiary, Mates Visa Consultancy Private Limited, has acquired 5,09,86,264 equity shares, representing 47.95% of the equity share capital of Bliss GVS Pharma Limited, pursuant to the completion of the share purchase agreement and the consequent mandatory open offer.

The share purchase agreement was executed amongst Anupam Rasayan India and the sellers, comprising the promoters of Bliss GVS Pharma and certain other shareholders.

Kanga & Co advised the sellers on the transaction, including advising on the transaction documentation, the open offer process and related regulatory disclosures and compliances and assisted the sellers through the execution and completion of the transaction.

The transaction team was led by Chetan Thakkar (Senior Partner), with support from Jalees Shaikh (Senior Associate) on the transaction documents, and Tejal Patankar (Principal Associate) along with Associates Sachi Ray, Vansh Chadha, Suphla Singh and Meghna Sharma on the open offer and securities law related aspects.

Bliss GVS Pharma is specialist in the development and manufacturing of suppositories and pessaries, alongside branded anti-malarials, contraceptives, anti-infectives, and gastrointestinal products.

Upon completion of the transaction, Anupam Rasayan India will acquire control over Bliss GVS Pharma.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.